Table 1.
Feature | Virus | Effect on Host | Refs. |
---|---|---|---|
Host genetic susceptibility | |||
TNF-α (−308) GG genotype IL-10 (-592/-819/-1082) CCA/ATA genotype IL-10 (-592/-819/-1082) ATA/ATG genotype |
Dengue | Development of severe dengue in Sri Lankan patients. Risk factor to developing DHF. Protective factor from DHF. |
[16] |
G6PD gene | Dengue, coronavirus, enterovirus | Deficiency enhances viral infection. | [17,18,19] |
A117V polymorphism in the NS2A | Zika | Increased virulence by reducing host innate immune responses and viral-induced apoptosis in vitro. | [20] |
HLA DRB1*11 | HCV | Protects from disease progression. | [21] |
HLA*0405, HLA DRB1*0301, DQB1*0201 | HCV | Viral persistence and chronic infection. | [22] |
IFIH1 | RSV | Deficient individuals unable to induce IFN-β, rendering them susceptible to infection. | [23] |
Q421X | IAV | Impaired IFN-α production causes life-threatening condition. | [24] |
Ageing | |||
Axl, Mertk | WNV | Age-related upregulation of regulatory receptors facilitates viral uptake by increasing blood–brain barrier permeability. | [25] |
T-cell defects | WNV | Insufficient number and quality of effector antiviral T-cells underlie age-related susceptibility to WNV. | [26] |
Histone modifications | IAV | Age-associated altered histone expression decreases IFN production by myeloid DCs. | [27] |
miR-181a deficiency in T-cells | WNV | Hallmark of ageing. Impairs T-cell expansion, viral clearance, and recall response. |
[28] |
Ethnicity | |||
IFN | HCV | IFN effectiveness in blocking viral production significantly greater in White versus African-American patients. | [29] |
ACE2 | COVID-19 | ACE2 (receptor for cellular entry) expression significantly higher among Asians compared to African-Americans and Caucasians. | [30] |
Nab | Rubella | Individuals of African descent have significantly higher rubella-specific NAb levels than European or Hispanic individuals. | [31] |
Co-morbidities | |||
Obesity | Influenza H1N1 | Decreased CD8+ T-cell activation results in inability to mount protective immune response | [32] |
Asthma | IAV | Increased susceptibility to heterologous secondary influenza due to defective mucosal antibody responses. | [33] |
Cancer (melanoma/RCC) | Tumour antigen-specific Th2-type polarisation of CD4+ T-cell responses in the peripheral blood of patients with RCC or melanoma. | [34] | |
Type 2 airway disorders (allergic asthma, allergic rhinitis, CRSwNP) | HRV16 | Type 2 cytokines increase susceptibility to viral infection in airways via changing the epithelial structure and production of interferons. A Th2 bias induces a deficit in defending the mucosa against viral and bacterial infections. |
[35] |